<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03009643</url>
  </required_header>
  <id_info>
    <org_study_id>STiNO</org_study_id>
    <nct_id>NCT03009643</nct_id>
  </id_info>
  <brief_title>Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery</brief_title>
  <official_title>Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypoxemia is a common complication after aortic surgery. As this complication has an adverse
      effect on the postoperative course of the patient, early treatment is important; however, the
      mechanism of hypoxemia after surgery for acute aortic dissection remains unclear. Recently,
      the investigators found that inhaled Nitric Oxide can improve the oxygenation in some of
      these patients. The investigators are trying to evaluate the effectiveness and safety of
      inhaled Nitric Oxide in patients with refractory hypoxemia after aortic surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several risk factors for severe hypoxemia after aortic surgery have been reported including
      advanced age, obesity, smoking history, previous heart surgery,emergency surgery,reduced
      cardiac function, advanced chronic obstructive pulmonary disease, excessive volume of blood
      transfusion,and prolonged CPB time. The routine treatment includes lung protective mechanical
      ventilation, recruitment maneuvers and glucocorticoids.

      No previous clinical studies have reported the effectiveness and safety of inhaled Nitric
      Oxide in patients with refractory hypoxemia after aortic surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mechanical ventilation time (days)</measure>
    <time_frame>During whole ICU stay. From date of randomization until the date of death or discharge from ICU, up to 6 months.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>From date of randomization until the date of death or discharge from ICU, up to 6 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay (days)</measure>
    <time_frame>From date of randomization until the date of death or discharge from hospital, up to 6 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of ICU stay (days)</measure>
    <time_frame>From date of randomization until the date of death or discharge from ICU, up to 6 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital mortality</measure>
    <time_frame>From date of randomization until the date of death or discharge from hospital, up to 6 months.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Nitric Oxide</condition>
  <condition>Hypoxemia</condition>
  <condition>Aortic Surgery</condition>
  <arm_group>
    <arm_group_label>iNO Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are treated with iNO at a concentration of 5-10 ppm for 3-5 days according to the clinical conditions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients are treated without iNO.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhaled Nitric Oxide</intervention_name>
    <description>Patients are treated with iNO for 3-5 days.The concentration of inhaled Nitric Oxide is around 5-10ppm.</description>
    <arm_group_label>iNO Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>lung protective mechanical ventilation</intervention_name>
    <description>Mechanical ventilation in the SIMV mode (ventilators Evita 2 or 4,Dräger, Lübeck, Germany) with VT 6-8ml/kg</description>
    <arm_group_label>iNO Group</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hemodynamic monitoring</intervention_name>
    <description>Flotrac/Vigileo (Edwards Lifesciences) are used to guide the fluid management.</description>
    <arm_group_label>iNO Group</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult patients with refractory hypoxemia after aortic surgery;

          2. Accepting invasive mechanical ventilation;

          3. Chest X-ray and lung ultrasound to exclude the respiratory factors (eg. pulmonary
             edema, obstructive atelectasis, pleural effusion, pneumothorax) and hemodynamic
             factors (pericardial tamponade, acute pulmonary hypertension, intracardiac shunt);

          4. The ventilator parameters: PEEP&gt;10cmH2O, VT 6-8ml/kg;

          5. The PaO2/FiO2 &lt;= 100mmHg.

        Exclusion Criteria:

          1. Age &lt;18 years old;

          2. Pregnant women;

          3. Past medical history included COPD or mental illness;

          4. The serious infection or sepsis patients;

          5. Patients with pulmonary hypertension and right ventricular dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhe Luo, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Critical Care Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guo-wei Tu, MD</last_name>
    <phone>+8613501996995</phone>
    <email>tu.guowei@zs-hospital.sh.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guo-guang Ma, MD</last_name>
    <phone>+8615021519979</phone>
    <email>ma.guoguang@zs-hospital.sh.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai Zhongshan Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guo-wei Tu, MD</last_name>
      <phone>+8613501996995</phone>
      <email>tu.guowei@zs-hospital.sh.cn</email>
    </contact>
    <contact_backup>
      <last_name>Zhe Luo, PhD</last_name>
      <phone>+13916127028</phone>
      <email>luo.zhe@zs-hospital.sh.cn</email>
    </contact_backup>
    <investigator>
      <last_name>Guang-wei Hao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guo-guang Ma, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=YfqLYB3FLh1ffnvcS2xPQmxTp1TQkLvvV6yfsC8prlyzldBHhvXy!1080955772!181195628!8091!-1?issn=0952-7907&amp;volume=27&amp;issue=2&amp;spage=146</url>
    <description>Lippincott Williams &amp; Wilkins, Inc</description>
  </link>
  <link>
    <url>http://link.springer.com/article/10.1007%2Fs00595-006-3226-5</url>
    <description>Springer</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649943/</url>
    <description>biomed central</description>
  </link>
  <link>
    <url>http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=YfrXyp1YcwF8gfV2DfS51PYLspPXJS3Wg1PhB2N4W6jQsmhG1Hnh!1080955772!181195628!8091!-1?issn=1070-5295&amp;volume=22&amp;issue=4&amp;spage=379</url>
    <description>Lippincott Williams &amp; Wilkins</description>
  </link>
  <link>
    <url>http://www.nature.com/nature/journal/v327/n6122/abs/327524a0.html</url>
    <description>Nature Publishing Group</description>
  </link>
  <link>
    <url>http://circ.ahajournals.org/content/83/6/2038.long</url>
    <description>HighWire</description>
  </link>
  <link>
    <url>http://www.sciencedirect.com/science/article/pii/S108986031530001X</url>
    <description>Elsevier Science</description>
  </link>
  <link>
    <url>http://www.nejm.org/doi/full/10.1056/NEJMra051884</url>
    <description>NEJM</description>
  </link>
  <link>
    <url>http://www.nejm.org/doi/full/10.1056/NEJM200002173420704</url>
    <description>NEJM</description>
  </link>
  <link>
    <url>http://pediatrics.aappublications.org/content/104/5/1089.long?sso=1&amp;sso_redirect_count=1&amp;nfstatus=401&amp;nftoken=00000000-0000-0000-0000-000000000000&amp;nfstatusdescription=ERROR%3a+No+local+token</url>
    <description>Pediatrics</description>
  </link>
  <reference>
    <citation>García-Delgado M, Navarrete-Sánchez I, Colmenero M. Preventing and managing perioperative pulmonary complications following cardiac surgery. Curr Opin Anaesthesiol. 2014 Apr;27(2):146-52. doi: 10.1097/ACO.0000000000000059. Review.</citation>
    <PMID>24514031</PMID>
  </reference>
  <reference>
    <citation>Ball L, Battaglini D, Pelosi P. Postoperative respiratory disorders. Curr Opin Crit Care. 2016 Aug;22(4):379-85. doi: 10.1097/MCC.0000000000000312. Review.</citation>
    <PMID>27168252</PMID>
  </reference>
  <reference>
    <citation>Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. N Engl J Med. 2005 Dec 22;353(25):2683-95. Review.</citation>
    <PMID>16371634</PMID>
  </reference>
  <results_reference>
    <citation>Nakajima T, Kawazoe K, Izumoto H, Kataoka T, Niinuma H, Shirahashi N. Risk factors for hypoxemia after surgery for acute type A aortic dissection. Surg Today. 2006;36(8):680-5.</citation>
    <PMID>16865510</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang Y, Xue S, Zhu H. Risk factors for postoperative hypoxemia in patients undergoing Stanford A aortic dissection surgery. J Cardiothorac Surg. 2013 Apr 30;8:118. doi: 10.1186/1749-8090-8-118.</citation>
    <PMID>23631417</PMID>
  </results_reference>
  <results_reference>
    <citation>Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11-17;327(6122):524-6.</citation>
    <PMID>3495737</PMID>
  </results_reference>
  <results_reference>
    <citation>Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991 Jun;83(6):2038-47. Erratum in: Circulation 1991 Nov;84(5):2212.</citation>
    <PMID>2040056</PMID>
  </results_reference>
  <results_reference>
    <citation>Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 1993 Mar;78(3):427-35.</citation>
    <PMID>8457043</PMID>
  </results_reference>
  <results_reference>
    <citation>Benedetto M, Romano R, Baca G, Sarridou D, Fischer A, Simon A, Marczin N. Inhaled nitric oxide in cardiac surgery: Evidence or tradition? Nitric Oxide. 2015 Sep 15;49:67-79. doi: 10.1016/j.niox.2015.06.002. Epub 2015 Jul 14. Review.</citation>
    <PMID>26186889</PMID>
  </results_reference>
  <results_reference>
    <citation>Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med. 2000 Feb 17;342(7):469-74.</citation>
    <PMID>10675427</PMID>
  </results_reference>
  <results_reference>
    <citation>Cornfield DN, Maynard RC, deRegnier RA, Guiang SF 3rd, Barbato JE, Milla CE. Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension. Pediatrics. 1999 Nov;104(5 Pt 1):1089-94.</citation>
    <PMID>10545552</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2016</study_first_submitted>
  <study_first_submitted_qc>January 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2017</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Zhongshan Hospital</investigator_affiliation>
    <investigator_full_name>Guowei Tu</investigator_full_name>
    <investigator_title>Attending doctor, Department of cardiac surgery intensive care unit, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Nitric Oxide</keyword>
  <keyword>hypoxemia</keyword>
  <keyword>aortic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

